There are 9 resources available
Acquired resistance to NTRK Inhibitors and development of inhibitors targeting resistance mutations
Presenter: U. N. Lassen, DK
Session: SESSION 5 Clinical development of NTRK inhibitors
Resources:
Multi-Kinases inhibitors with NTRK as a possible target
Presenter: D. Planchard, FR
Session: SESSION 5 Clinical development of NTRK inhibitors
Tolerance profile and recommendation for use
Presenter: D. Planchard, FR
Session: SESSION 5 Clinical development of NTRK inhibitors
Present results with Larotectinib
Presenter: U. N. Lassen, DK
Session: SESSION 5 Clinical development of NTRK inhibitors
Detection of gene fusion within the ESMO scale of Molecular Target (ESCAT)
Presenter: J. Mateo, ES
Session: SESSION 4 Detection of gene fusion within the ESMO scale of Molecular Target (ESCAT)
Identification/testing methodologies and challenges
Presenter: C. Marchiò, IT
Session: SESSION 3 Identification/testing methodologies and challenges
Epidemiology and distribution of NTRK gene fusion in human tumours
Presenter: S. Ramon y Cajal, ES
Session: SESSION 2 Epidemiology and distribution of NTRK gene fusion in human tumours
Mechanisms of gene fusion, fusion partners and consequences in oncogenesis Description, structure and function of TRK and NTRK in ontogenesis
Presenter: A. Vivancos, ES
Session: SESSION 1 Keynote lecture - Gene fusion in human cancer
Welcome and Introduction
Presenter: C. Marchiò, IT E. Garralda, ES
Session: Welcome and Introduction